Life Sciences Commercializer - Thad Bench of Benchworks

Thad Bench, the CEO of Benchworks, grew his company's revenue from $8 million in 2014 to $42.4 million in 2017, a 428% increase, and to around $68 million in 2018.   Benchworks is a fully integrated life sciences commercialization partner.   In this interview with Eversprint's Malcolm Lui, Thad shares how he and his team accelerated their high value sales by:   Surrounding themselves with giants who have the skills their business needs.  Innovating on the entire spectrum of their services from marketing to distribution to technology.  Identifying and providing better services to under-served markets, such as smaller pharmacies.